摘要
淀粉样生成是2型糖尿病(T2D)和阿尔茨海默病(AD)的病理学特点。这些疾病的特点是胰腺部位胰岛淀粉样多肽(IAPP)的胞外淀粉样沉积和脑内β淀粉样蛋白(Aβ)。因为IAPP可能进入大脑,并且不同的淀粉样蛋白可能相互交叉培育来增加淀粉样生成,我们假设胰腺源IAPP可以进入大脑,而增加AD中Aβ的错折叠。这种推论假设的正确性是IAPP[1]进入大脑,[2]增加Aβ的错折叠,[3]与Aβ斑块联系在一起,并且最重要的是[4]血浆水平与AD诊断一致。我们展示了最早的3种推论:(1)IAPP存在于人类脑脊髓液(CSF)中,(2) 合成IAPP可以促进体外Aβ聚合,及(3)内源性IAPP局限于Aβ单体和斑块。对于第4种推论,在非裔美国人组群和转基因AD小鼠中,我们没有观察到与AD病理相关的外周IAPP水平。在非裔美国人组群中,随着T2D 和AD 风险的增加,样本的外周IAPP水平与无疾病、T2D、AD或者同时患有T2D和AD者明显不同。Tg2576 AD 老鼠模型,在老鼠显示糖尿病前期的葡萄糖耐受不良阶段IAPP血浆水平提高不太明显。基于这种负面数据,在AD脑内,外周IAPP交杂培育或者“感染”AD脑内的Aβ病理似乎不太可能。然而,我们提供的新颖和额外的数据表明IAPP蛋白存在于小鼠大脑星形胶质细胞,由原代培养星形胶质细胞分泌。此初步报告暗示了脑源IAPP与AD之间的潜在和创新性联系,然而是否源于IAPP的星形细胞是否与大脑Aβ交叉培育仍然需要进一步的研究。
关键词: 阿尔茨海默病,β淀粉样,胰淀素,血液,脑部,免疫组织化学,代谢紊乱,低聚物,斑块,2型糖尿病
Current Alzheimer Research
Title:Islet Amyloid Polypeptide (IAPP): A Second Amyloid in Alzheimer's Disease
Volume: 11 Issue: 10
Author(s): Janelle N. Fawver, Yonatan Ghiwot, Catherine Koola, Wesley Carrera, Jennifer Rodriguez-Rivera, Caterina Hernandez, Kelly T. Dineley, Yu Kong, Jianrong Li, Jack Jhamandas, George Perry and Ian V.J. Murray
Affiliation:
关键词: 阿尔茨海默病,β淀粉样,胰淀素,血液,脑部,免疫组织化学,代谢紊乱,低聚物,斑块,2型糖尿病
摘要: Amyloid formation is the pathological hallmark of type 2 diabetes (T2D) and Alzheimer’s disease (AD). These diseases are marked by extracellular amyloid deposits of islet amyloid polypeptide (IAPP) in the pancreas and amyloid β (Aβ) in the brain. Since IAPP may enter the brain and disparate amyloids can cross-seed each other to augment amyloid formation, we hypothesized that pancreatic derived IAPP may enter the brain to augment misfolding of Aβ in AD. The corollaries for validity of this hypothesis are that IAPP [1] enters the brain, [2] augments Aβ misfolding, [3] associates with Aβ plaques, and most importantly [4] plasma levels correlate with AD diagnosis. We demonstrate the first 3 corollaries that: (1) IAPP is present in the brain in human cerebrospinal fluid (CSF), (2) synthetic IAPP promoted oligomerization of Aβ in vitro, and (3) endogenous IAPP localized to Aβ oligomers and plaques. For the 4 corollary, we did not observe correlation of peripheral IAPP levels with AD pathology in either an African American cohort or AD transgenic mice. In the African American cohort, with increased risk for both T2D and AD, peripheral IAPP levels were not significantly different in samples with no disease, T2D, AD, or both T2D and AD. In the Tg2576 AD mouse model, IAPP plasma levels were not significantly elevated at an age where the mice exhibit the glucose intolerance of pre-diabetes. Based on this negative data, it appears unlikely that peripheral IAPP cross-seeds or “infects” Aβ pathology in AD brain. However, we provide novel and additional data which demonstrate that IAPP protein is present in astrocytes in murine brain and secreted from primary cultured astrocytes. This preliminary report suggests a potential and novel association between brain derived IAPP and AD, however whether astrocytic derived IAPP cross-seeds Aβ in the brain requires further research.
Export Options
About this article
Cite this article as:
Janelle N. Fawver, Yonatan Ghiwot, Catherine Koola, Wesley Carrera, Jennifer Rodriguez-Rivera, Caterina Hernandez , Kelly T. Dineley, Yu Kong, Jianrong Li, Jack Jhamandas, George Perry and Murray V.J. Ian, Islet Amyloid Polypeptide (IAPP): A Second Amyloid in Alzheimer's Disease, Current Alzheimer Research 2014; 11 (10) . https://dx.doi.org/10.2174/1567205011666141107124538
DOI https://dx.doi.org/10.2174/1567205011666141107124538 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anti-inflammatory Action of Green Tea
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Patent Selections
Recent Patents on Drug Delivery & Formulation Low Birth Weight and Risk of Obesity - A Potential Problem for the Japanese People
Current Women`s Health Reviews Hybrid Imaging in Evaluation of Abdominal Sarcoidosis
Current Medical Imaging Clozapine Safety, 35 Years Later
Current Drug Safety Monoclonal Antibody-Based Targeted Therapy in Breast Cancer
Current Medicinal Chemistry - Anti-Cancer Agents Low Testosterone Levels and Metabolic Syndrome in Aging Male
Current Pharmaceutical Design Chronic Hyperuricemia, Uric Acid Deposit and Cardiovascular Risk
Current Pharmaceutical Design Assessing Coronary Blood Flow Physiology in the Cardiac Catheterisation Laboratory
Current Cardiology Reviews Ameliorative Effect of Phosphodiesterase-5 Inhibitor in Rat Model of Vascular Dementia
Current Neurovascular Research The Role of TNFSF15 in the Modulation of Neovascularization and Inflammation
Current Hypertension Reviews From The Editors Perspective: Unlocking the Secrets to Cell Survival and Longevity
Current Neurovascular Research Development of Calorie Restriction Mimetics as Therapeutics for Obesity, Diabetes, Inflammatory and Neurodegenerative Diseases
Current Genomics Potassium Channel Openers and Improvement of Toxic Stress: Do they have Role in the Management of Inflammatory Bowel Disease?
Inflammation & Allergy - Drug Targets (Discontinued) Correlation Between Circulating Adhesion Molecules and Resistin Levels in Hypertensive Type-2 Diabetic Patients
Inflammation & Allergy - Drug Targets (Discontinued) Role of PPAR in Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Co-administration of Phycocyanobilin and/or Phase 2-Inducer Nutraceuticals for Prevention of Opiate Tolerance
Current Pharmaceutical Design Reduction in Estimated Glomerular Filtration Rate (eGFR) Results in an Increased Risk of Spontaneous Hemorrhagic Transformation in Patients with Large-artery Atherosclerosis Stroke
Current Neurovascular Research Early, Intensive and Long-term Statin Therapy in Acute Coronary Syndrome: Focus on Anti-inflammatory Mechanisms
Vascular Disease Prevention (Discontinued) Use of Clinically Available PPAR Agonists for Heart Failure; Do the Risks Outweigh the Potential Benefits?
Current Molecular Pharmacology